These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28523431)
1. The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool. Bastiaens L; Galus J Psychiatr Q; 2018 Mar; 89(1):111-115. PubMed ID: 28523431 [TBL] [Abstract][Full Text] [Related]
2. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale. Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528 [TBL] [Abstract][Full Text] [Related]
3. First-episode types in bipolar disorder: predictive associations with later illness. Baldessarini RJ; Tondo L; Visioli C Acta Psychiatr Scand; 2014 May; 129(5):383-92. PubMed ID: 24152091 [TBL] [Abstract][Full Text] [Related]
4. Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview. Recklitis CJ; Blackmon JE; Chang G Psychol Assess; 2017 Oct; 29(10):1189-1200. PubMed ID: 28080106 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care. Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303 [TBL] [Abstract][Full Text] [Related]
6. Validation of hindi translation of DSM-5 level 1 cross-cutting symptom measure. Goel A; Kataria D Asian J Psychiatr; 2018 Apr; 34():6-10. PubMed ID: 29567481 [TBL] [Abstract][Full Text] [Related]
7. DSM depression and anxiety criteria and severity of symptoms in primary care: cross sectional study. Nease DE; Aikens JE BMJ; 2003 Nov; 327(7422):1030-1. PubMed ID: 14593040 [No Abstract] [Full Text] [Related]
8. Concordance of self-rated and observer-rated dysphoric symptoms in mania. Cassidy F; Ahearn E; Carroll BJ J Affect Disord; 2009 Apr; 114(1-3):294-8. PubMed ID: 18684512 [TBL] [Abstract][Full Text] [Related]
9. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory. Preljevic VT; Østhus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418 [TBL] [Abstract][Full Text] [Related]
10. A validation study of the Four-Dimensional Symptom Questionnaire (4DSQ) in insurance medicine. Langerak W; Langeland W; van Balkom A; Draisma S; Terluin B; Draijer N Work; 2012; 43(3):369-80. PubMed ID: 22927600 [TBL] [Abstract][Full Text] [Related]
11. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis. Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239 [TBL] [Abstract][Full Text] [Related]
12. Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation. Van Meter A; Guinart D; Bashir A; Sareen A; Cornblatt BA; Auther A; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Cascio NL; Correll CU J Affect Disord; 2019 Apr; 249():357-365. PubMed ID: 30807937 [TBL] [Abstract][Full Text] [Related]
13. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Bech P; Kastrup M; Rafaelsen OJ Acta Psychiatr Scand Suppl; 1986; 326():1-37. PubMed ID: 3458353 [No Abstract] [Full Text] [Related]
14. Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients. Yang Y; Ding R; Hu D; Zhang F; Sheng L Compr Psychiatry; 2014 Jan; 55(1):215-20. PubMed ID: 24199886 [TBL] [Abstract][Full Text] [Related]
16. The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. Azorin JM; Akiskal H; Hantouche E J Affect Disord; 2006 Dec; 96(3):215-23. PubMed ID: 16427134 [TBL] [Abstract][Full Text] [Related]
17. Validation of the DSM-5 Level 1 Cross-Cutting Symptom Measure in a Community Sample. Doss RA; Lowmaster SE Psychiatry Res; 2022 Dec; 318():114935. PubMed ID: 36332507 [TBL] [Abstract][Full Text] [Related]
18. How much or how often? Examining the screening properties of the DSM cross-cutting symptom measure in a youth population-based sample. Gonçalves Pacheco JP; Kieling C; Manfro PH; Menezes AMB; Gonçalves H; Oliveira IO; Wehrmeister FC; Rohde LA; Hoffmann MS Psychol Med; 2024 Jul; 54(10):2732-2743. PubMed ID: 38639338 [TBL] [Abstract][Full Text] [Related]
19. Successful validation of the CAT-MH Scales in a sample of Latin American migrants in the United States and Spain. Gibbons RD; Alegría M; Cai L; Herrera L; Markle SL; Collazos F; Baca-García E Psychol Assess; 2018 Oct; 30(10):1267-1276. PubMed ID: 29792502 [TBL] [Abstract][Full Text] [Related]
20. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression. Smith DJ; Muir WJ; Blackwood DH J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]